Binka M, Janjua NZ, Grebely J, Estes C, Schanzer D, Kwon JA, Shoukry NH, Kwong JC, Razavi H, Feld JJ, Krajden M. Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated Model. JAMA Netw Open. 2020 May 1;3(5):e204192. doi: 10.1001/jamanetworkopen.2020.4192. PMID: 32374397; PMCID: PMC7203608. Summary Importance Achievement of the World […]
Idilman, R., Razavi, H., Robbins-Scott, S. et al. A micro-elimination approach to addressing hepatitis C in Turkey. BMC Health Serv Res 20, 249 (2020). https://doi.org/10.1186/s12913-020-5019-8 Summary Background In 2016, WHO passed the Global Health Sector Strategy on Viral Hepatitis (GHSS), calling for its elimination by 2030. Two years later, Turkey approved a strategy to reach the WHO targets. This study […]
Estes C, Chan HLY, Chien RN, Chuang WL, Fung J, Goh GB, Hu TH, Huang JF, Jang BK, Jun DW, Kao JH, Lee JW, Lin HC, Razavi-Shearer K, Seto WK, Wong GL, Wong VW, Razavi H. Modelling NAFLD disease burden in four Asian regions-2019-2030. Aliment Pharmacol Ther. 2020 Apr;51(8):801-811. doi: 10.1111/apt.15673. Epub 2020 Mar 4. […]
Schmelzer J, Dugan E, Blach S, Coleman S, Cai Z, DePaola M, Estes C, Gamkrelidze I, Jerabek K, Ma S, Montoya S, Razavi-Shearer D, Razavi-Shearer K, Robbins-Scott S, Razavi H, El Sayed MH. Global prevalence of hepatitis C virus in children in 2018: a modelling study. Lancet Gastroenterol Hepatol. 2020 Apr;5(4):374-392. doi: 10.1016/S2468-1253(19)30385-1. Epub 2020 […]
Benzaken AS, Girade R, Catapan E, Pereira GFM, Almeida EC, Vivaldini S, Fernandes N, Razavi H, Schmelzer J, Ferraz ML, Ferreira PRA, Pessoa MG, Martinelli A, Souto FJD, Walsh N, Mendes-Correa MC. Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach. Braz J Infect Dis. 2019 May-Jun;23(3):182-190. doi: […]
Kwon JA, Dore GJ, Grebely J, Hajarizadeh B, Guy R, Cunningham EB, Power C, Estes C, Razavi H, Gray RT; HCV Estimates and Projections Reference Group. Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study. J Viral Hepat. 2019 Jan;26(1):83-92. doi: 10.1111/jvh.13013. Epub 2018 Nov 14. […]
Gountas I, Sypsa V, Blach S, Razavi H, Hatzakis A. HCV elimination among people who inject drugs. Modelling pre- and post-WHO elimination era. PLoS One. 2018 Aug 16;13(8):e0202109. doi: 10.1371/journal.pone.0202109. PMID: 30114207; PMCID: PMC6095544. Summary Background Elimination of hepatitis C virus (HCV) among people who inject drugs (PWID) is a costly investment, so strategies should […]
Ntagirabiri, R. , Robbins, S. , Barasukana, P. , Munezero, B. and Manirakiza, M. (2018) Modeling the Epidemiological Landscape of Chronic Hepatitis C in a Sub-Saharan African Country: What Is Needed to Achieve Elimination by 2030 in Burundi?. Open Journal of Gastroenterology, 8, 284-293. doi: 10.4236/ojgas.2018.88031. Summary Background Chronic Hepatitis C virus (HCV) is an increasing threat to […]
Schaefer B, Viveiros A, Al-Zoairy R, Blach S, Brandon S, Razavi H, Dorn L, Finkenstedt A, Effenberger M, Graziadei I, Sarcletti M, Tilg H, Zoller H. Disease burden of hepatitis C in the Austrian state of Tyrol – Epidemiological data and model analysis to achieve elimination by 2030. PLoS One. 2018 Jul 12;13(7):e0200750. doi: 10.1371/journal.pone.0200750. […]
Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018 Jun;3(6):383-403. doi: 10.1016/S2468-1253(18)30056-6. Epub 2018 Mar 27. PMID: 29599078. Summary Collaborators Polaris Observatory Collaborators: Devin Razavi-Shearer, Ivane Gamkrelidze, Mindie H Nguyen, Ding-Shinn Chen, Pierre Van Damme, Zaigham Abbas, Maheeba Abdulla, Antoine Abou Rached, Danjuma Adda, Inka Aho, Ulus Akarca, Fuad Hasan, Faryal Al Lawati, Khalid Al Naamani, Hamad […]